TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
VYGR

Voyager Therapeutics Inc

Healthcare · Biotechnology

1.80$ +2.8% vs. previous close Closing price · As of: Nov 3, 2026

Ownership

Ownership Structure

Who owns Voyager Therapeutics Inc (VYGR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 72.2% of the shares are freely tradable; institutional investors hold 56.4%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 56.4%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 15.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 72.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 7.6%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 62Mio.

Largest Shareholders

Institutions

Institutions VYGR
Name Stake (%) Shares Change (%) Date
BlackRock Inc 8.39 5,172,063 -7.1 06/30/2026
Millennium Management LLC 7.21 4,442,951 +29.6 06/30/2026
Armistice Capital, LLC 5.58 3,436,000 -1.8 06/30/2026
Vestal Point Capital LP 4.26 2,625,000 -12.6 06/30/2026
Vanguard Capital Management, LLC 3.81 2,345,674 +2.7 06/30/2026
Geode Capital Management, LLC 2.16 1,330,492 +26.7 06/30/2026
Opaleye Management Inc 1.92 1,185,000 +3.0 06/30/2026
State Street Corp 1.75 1,076,422 +13.5 06/30/2026

Funds

Funds VYGR
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.71 1,671,885 +0.0 09/30/2026
iShares Russell 2000 ETF 2.24 1,383,008 -1.1 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?